|
1
|
Chen W: Cancer statistics: Updated cancer
burden in China. Chin J Res. 27:12015.
|
|
2
|
Karimkhani C, Green AC, Nijsten T,
Weinstock MA, Dellavalle RP, Naghavi M and Fitzmaurice C: The
global burden of melanoma: Results from the global burden of
disease study 2015. Br J Dermatol. 177:134–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tsao H, Chin L, Garraway LA and Fisher DE:
Melanoma: From mutations to medicine. Genes Dev. 26:1131–1155.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Farma JM, Kulkarni N and Hsu C: Surgical
management of primary and recurrent melanoma. Surg Oncol Clin N Am.
24:239–247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hocker T and Tsao H: Ultraviolet radiation
and melanoma: A systematic review and analysis of reported sequence
variants. Hum Mutat. 28:578–588. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Silverberg JI and Ratner D: Associations
of non-melanoma skin cancer and melanoma, extra-cutaneous cancers
and smoking in adults: A US population-based study. J Eur Acad
Dermatol Venereol. 29:1389–1397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo L, Tang H, Ling L, Li N, Jia X, Zhang
Z, Wang X, Shi L, Yin J, Qiu N, et al: LINC01638 lncRNA activates
MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation
in triple-negative breast cancer. Oncogene. 37:6166–6179. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hodi FS, O'Day SJ, McDermott DF, Weber RW,
Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel
JC, et al: Improved survival with ipilimumab in patients with
metastatic melanoma. N Engl J Med. 363:711–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schadendorf D, Hodi FS, Robert C, Weber
JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM and Wolchok JD:
Pooled analysis of long-term survival data from phase II and phase
III trials of ipilimumab in unresectable or metastatic melanoma. J
Clin Oncol. 33:1889–1894. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
American Academy of Dermatology Ad Hoc
Task Force for the ABCDEs of Melanoma, ; Tsao H, Olazagasti JM,
Cordoro KM, Brewer JD, Taylor SC, Bordeaux JS, Chren MM, Sober AJ,
Tegeler C, et al: Early detection of melanoma: Reviewing the
ABCDEs. J Am Acad Dermatol. 72:717–723. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grammatikakis I, Panda AC, Abdelmohsen K
and Gorospe M: Long noncoding RNAs(lncRNAs) and the molecular
hallmarks of aging. Aging (Albany NY). 6:992–1009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Qiu M, Xu Y, Li M, Dong G, Mao Q,
Yin R and Xu L: Long noncoding RNA CCAT2 correlates with smoking in
esophageal squamous cell carcinoma. Tumour Biol. 36:5523–5528.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng L, Liu J, Wang Y, Wang L, Weng S,
Tang Y, Zheng C, Cheng Q, Chen S and Yang GY: MicroRNA-210 as a
novel blood biomarker in acute cerebral ischemia. Front Biosci
(Elite Ed). 3:1265–1272. 2011.PubMed/NCBI
|
|
18
|
Shehadeh LA, Yu K, Wang L, Guevara A,
Singer C, Vance J and Papapetropoulos S: SRRM2, a potential blood
biomarker revealing high alternative splicing in Parkinson's
disease. PLoS One. 5:e91042010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Gao G, Liu S, Yu L, Yan D, Yao X,
Sun W, Han D and Dong H: Long noncoding RNA PVT1 as a novel
diagnostic biomarker and therapeutic target for melanoma. Biomed
Res Int. 2017:70385792017.PubMed/NCBI
|
|
20
|
Long J and Pi X: lncRNA-MEG3 suppresses
the proliferation and invasion of melanoma by regulating CYLD
expression mediated by sponging miR-499-5p. Biomed Res Int.
2018:20865642018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mallidi S, Watanabe K, Timerman D,
Schoenfeld D and Hasan T: Prediction of tumor recurrence and
therapy monitoring using ultrasound-guided photoacoustic imaging.
Theranostics. 5:289–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mattonen SA, Palma DA, Haasbeek CJ, Senan
S and Ward AD: Early prediction of tumor recurrence based on CT
texture changes after stereotactic ablative radiotherapy (SABR) for
lung cancer. Med Phys. 41:0335022014. View Article : Google Scholar : PubMed/NCBI
|
